Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BH4 for Radiation-Induced Skin Injury in Vulvar Cancer
NCT05114226Phase 1Unknown
- Sponsor
- West China Second University Hospital
- Start
- Mar 2022
- Primary completion
- Nov 2023
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label trial of sapropterin in radiation dermatitis, sponsored by West China Second University Hospital. Status: unknown.
02
Drugs
sapropterin
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT05114226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05114226.